Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
基本信息
- 批准号:8210908
- 负责人:
- 金额:$ 35.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:3-nitrotyrosineATP2A2AbbreviationsAccountingAcuteAffectAnimalsAntibodiesAntioxidantsAreaArgentinaAtrial Natriuretic FactorBiochemicalBiochemistryBiogenesisBioinformaticsBiological MarkersBiological PreservationBiologyBiopsyBlood specimenBrain natriuretic peptideCardiacCardiac MyocytesCardiomyopathiesCardiovascular systemCellular MorphologyCellular biologyCessation of lifeChagas DiseaseCharacteristicsChronicChronic DiseaseClassificationClinicalCollaborationsCombined Modality TherapyCommunicable DiseasesComplexCreatine KinaseCreatinineCross-Sectional StudiesCustomDataDatabasesDefectDevelopmentDiseaseDisease susceptibilityEchocardiographyElectrocardiogramEngineeringEnrollmentEnsureEnvironmentEnzymesEquilibriumEtiologyEvolutionExhibitsExperimental ModelsExtracellular MatrixFibrosisFluorescenceFunctional disorderGene ExpressionGene ProteinsGenesGlutamatesGlutathioneGlutathione DisulfideGoalsHealthHeartHeart failureHomeostasisHospitalsHumanIndividualInfectionInjuryInstitutesIntegration Host FactorsInternationalJointsLaboratoriesLeadLeft Ventricular FunctionLeft ventricular structureLiquid ChromatographyLiquid substanceLuxonMalondialdehydeManganese Superoxide DismutaseMetabolicMetabolismMexicoMitochondriaMitochondrial ProteinsMolecularMusMyocardialMyosin Heavy ChainsNADH dehydrogenase (ubiquinone)OrganOutputOxaloacetatesOxidantsOxidative StressOxidoreductaseParasite ControlParasitesPathogenesisPathologicPathologic ProcessesPathologistPathologyPathway interactionsPatientsPatternPerformancePeripheralPeripheral Blood Mononuclear CellPharmaceutical PreparationsPhasePhosphotransferasesPlasmaPlasma ProteinsPlayPositioning AttributePredispositionPreventionProcessProductionProteinsProteomeProtocols documentationPyruvateReactive Oxygen SpeciesReagentReduced GlutathioneResearchRespiratory ChainReticulumRiskRisk FactorsRoleSamplingScientistSerologic testsSeverity of illnessSignal TransductionSiteStagingStructureSymptomsSystemTestingTissuesTrainingTransaminasesTroponinTrypanosomaTrypanosoma cruziVentricular RemodelingWestern Blottingbasebiological adaptation to stresscell injurycombinatorialcomparativedesigndisability-adjusted life yearsexperiencegel electrophoresisglutathione peroxidaseheart functionheart rhythmhuman morbidityhuman subjectinnovationinorganic phosphateinsightmitochondrial dysfunctionmortalitynitronenoveloxidationoxidative damageperipheral bloodphenyl-N-tert-butylnitronepreventrespiratoryresponsescreeningtwo-dimensionalubiquinol
项目摘要
DESCRIPTION (provided by applicant): Chronic chagasic cardiomyopathy (CCM) is a major cause for heart failure related mortality and morbidity of humans. Trypanosoma cruzi is the etiological agent, however, clinical disease does not correlate with parasite presence, and host factors are likely involved in activation and/or sustenance of CCM pathogenesis. In recent studies, we have shown that chagasic animals and patients sustain mitochondrial dysfunction of respiratory chain. At functional level, mitochondrial damage resulted in a decrease in energy output and an increase in oxidative stress both of which can play a pivotal role in cardiovascular homeostasis associated with CCM. Thus, in this proposal, we plan to investigate the critical importance of mitochondrial dysfunction and oxidative stress in human Chagas disease severity. Our central hypothesis is that infection by T. cruzi elicits mt damage in cardiomyocytes that results in a continuing cycle of respiratory chain inefficiency and ROS formation. These ROS cause cellular oxidative damage, and lead to the development of progressive cardiac pathology and impaired LV function in human chagasic patients. To test this hypothesis, we will conduct a cross-sectional study with following specific aims: 1) Identify the molecular, biochemical, and functional changes in mt that cause impaired metabolic activity and constitute a risk factor in human Chagas disease, 2) Determine how ROS-induced oxidative cellular damage enhance the patients' risk to develop clinical symptoms of Chagas disease, and 3) Identify the molecular pathways that are affected by mt and cellular oxidative stress and contribute to myocardial structural and functional alterations during progressive CCM. Samples from cardiomyopathy patients of other etiologies and healthy subjects will be analyzed for comparison purposes. Upon completion of the proposed studies, we anticipate demonstrating the importance of oxidative stress in instigation and/or sustenance of pathological processes (mt metabolic alterations, oxidative processes, cardiac remodeling) during CCM development. The comparative analysis with cardiomyopathy patients of other etiologies would provide insight into the mechanisms of cardiomyopathy development, and identify whether inhibiting oxidative responses would be useful in preventing cardiac damage. We anticipate identifying novel targets for the development of combinatorial therapies for preserving the cardiomyocyte composition and heart function that will be useful in controlling the onset/progression of chronic cardiomyopathy. We will conduct these studies in collaboration with multiple national and international collaborators, and as a result, our collaborators at the Argentina study site will gain training in cutting edge molecular and biochemical approaches, thus, enhancing their research capabilities in cardiovascular infectious diseases.
描述(由申请人提供):慢性chagasic心肌病(CCM)是人类与心力衰竭相关的死亡率和发病率的主要原因。克鲁齐锥虫是病因,但是,临床疾病与寄生虫的存在无关,宿主因子可能参与CCM发病机理的激活和/或维持。在最近的研究中,我们表明chagasic动物和患者维持呼吸链的线粒体功能障碍。在功能水平上,线粒体损伤导致能量输出降低和氧化应激的增加,这两者都可以在与CCM相关的心血管稳态中起关键作用。因此,在该提案中,我们计划研究人类chagas疾病严重程度中线粒体功能障碍和氧化应激的关键重要性。我们的中心假设是,克鲁齐(T. cruzi)的感染引起了心肌细胞中MT损伤,从而导致呼吸链效率低下和ROS形成的持续循环。这些ROS会导致细胞氧化损伤,并导致人类chagasic患者的进行性心脏病理的发展和LV功能受损。为了检验这一假设,我们将进行以下特定目的进行横截面研究:1)确定MT中的分子,生化和功能变化,导致造成代谢障碍的危险因素,并构成人类Chagas疾病的危险因素,2)确定ROS诱导的氧化细胞损害如何增强患者的临床症状,并确定chagas病的风险,并确定chagas病的临床症状,并确定chagas症状的临床症状,并确定3)分子的临床症状,并确定3)。氧化应激并有助于进行性CCM期间的心肌结构和功能改变。将分析来自其他病因和健康受试者的心肌病患者的样本,以进行比较。拟议的研究完成后,我们预计将证明氧化应激在CCM发育过程中氧化应激在煽动和/或维持病理过程(MT代谢改变,氧化过程,心脏重塑)中的重要性。与其他病因的心肌病患者的比较分析将提供对心肌病发育机制的见解,并确定抑制氧化反应是否对预防心脏损伤有用。我们预计,可以识别出用于保留心肌细胞组成和心脏功能的组合疗法的新靶标,这将有助于控制慢性心肌病的发作/进展。我们将与多个国家和国际合作者合作进行这些研究,结果,我们在阿根廷研究站点的合作者将获得有关尖端分子和生化方法的培训,从而增强了他们在心血管传染病中的研究能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nisha Jain Garg其他文献
NADPH Oxidase: Role in Progression of Myocarditis During Trypanosoma cruzi Infection and Chagas Disease
- DOI:
10.1016/j.freeradbiomed.2010.10.393 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Nisha Jain Garg;Monisha Dhiman - 通讯作者:
Monisha Dhiman
Nisha Jain Garg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nisha Jain Garg', 18)}}的其他基金
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Mitochondrial Biomarkers of Cardiomyopathy and Cure in Chagas Disease
心肌病的线粒体生物标志物和恰加斯病的治疗
- 批准号:
8666721 - 财政年份:2013
- 资助金额:
$ 35.82万 - 项目类别:
Mitochondrial Biomarkers of Cardiomyopathy and Cure in Chagas Disease
心肌病的线粒体生物标志物和恰加斯病的治疗
- 批准号:
8568036 - 财政年份:2013
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7994825 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7567886 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
9751200 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
9571194 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
10219916 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7752870 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Human serum carbonyl proteome in cardiovascular diseases
心血管疾病中的人血清羰基蛋白质组
- 批准号:
7530425 - 财政年份:2008
- 资助金额:
$ 35.82万 - 项目类别:
相似国自然基金
基于单细胞测序解析miR-4632靶向ATP2A2调控NLRP3焦亡信号促进肺动脉高压血管重塑的作用机制研究
- 批准号:82241015
- 批准年份:2022
- 资助金额:50.00 万元
- 项目类别:专项项目
TMEM8B-a多聚化修饰降解ATP2A2蛋白抑制肺癌细胞集体侵袭的分子机制及相应靶向抑制剂转化应用研究
- 批准号:82172879
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
重度智力障碍并癫痫候选易感/致病基因ATP2A2、RYR1和RYR2分析验证及发病机制的研究
- 批准号:81771408
- 批准年份:2017
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7567886 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7752870 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Kinases-mediated SUMOylation in Diabetic Cardiomyopathy
糖尿病心肌病中激酶介导的 SUMO 化
- 批准号:
7373477 - 财政年份:2008
- 资助金额:
$ 35.82万 - 项目类别:
Regulation and Function of Phosphodiesterase in the Heart
心脏中磷酸二酯酶的调节和功能
- 批准号:
7380904 - 财政年份:2008
- 资助金额:
$ 35.82万 - 项目类别:
Regulation and Function of Phosphodiesterase in the Heart
心脏中磷酸二酯酶的调节和功能
- 批准号:
7555646 - 财政年份:2008
- 资助金额:
$ 35.82万 - 项目类别: